Novel therapeutics for the remediation of social deficits in psychiatric illness

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1088711

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Many psychiatric disorders feature a disruption of social behaviour as a central feature of the illness. Examples includes autism, social anxiety disorder, schizophrenia and the addictions. Existing therapies for these disorders rarely improve these core social deficits. We have recently discovered a new molecule (called SOC-1) that stimulates social behaviour in animals. The current project will study how SOC-1 produces these effects and will develop it as a medication for human use.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $597,719.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biologically Active Molecules

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anxiety disorders | drug discovery | medicinal chemistry | mental health | oxytocin

Related Links